Welcome to the e-CCO Library!

P455: Aminosalicylates in Ulcerative Colitis: old but gold?
Year: 2022
Source: ECCO'22
Authors: Sequeira, C.(1);Santos, I.(1);Coelho, M.(1);Teixeira, C.(1);Mangualde, J.(1);Cremers, I.(1);Oliveira, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P455: Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Estévez-Gil M.1, De Castro M.L.*2, Hernández V.2, Pineda J.R.2, Martínez-Cadilla J.2, Pereira S.2, Rodríguez-Prada J.-I.2

Created: Wednesday, 20 February 2019, 10:36 AM
P455: Comparison of two strategies for the management of post-operative recurrence in Crohn's disease patients with one clinical risk factor: a multicentre IG-IBD study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dragoni, G.(1)*;Castiglione, F.(2);Bezzio, C.(3);Pugliese, D.(4);Spagnuolo, R.(5);Viola, A.(6);Cocomazzi, F.(7);Aratari, A.(8);Savarino, E.V.(9);Balestrieri, P.(10);Onali, S.(11);Viganò, C.(12);Ribaldone, D.G.(13);Innocenti, T.(14);Testa, A.(2);Saibeni, S.(3);Privitera, G.(4);Milla, M.(14);Armuzzi, A.(15);Fantini, M.C.(11);Fiorino, G.(16);
Created: Friday, 14 July 2023, 11:05 AM
P455: Evaluation of the optic nerve function in patients with ulcerative colitis and Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Skamnelos*1, A. Kavvadias1, P. Zafeiropoulos2, K. Katsanos1, I. Asproudis2, D. Christodoulou1

Created: Friday, 22 February 2019, 9:41 AM
P455: Spacing of infliximab infusions over 8 weeks in patients with inflammatory bowel diseases in clinical remission: Final results of a retrospective multicentre French national cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Dufour1*, B. Pariente2, A. Amiot3, S. Viennot4, F. Zerbib5, L. Caillo6, S. Nancey7, P. Pouderoux6, F. Poullenot5, R. Altwegg1, L. Peyrin-Biroulet8, M. Nachury2, P. Blanc1, G. Pineton de Chambrun1

Created: Thursday, 21 February 2019, 9:14 AM
P455: The effect of concurrent HIV-1 infection on the management of patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. H. Ho, R. Fausel, J. Torres, J. J. Yang, T. H. Swartz, J. A. Aberg, J.-F. Colombel, S. Mehandru*

Created: Friday, 22 February 2019, 9:49 AM
P455: Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Silfen, A.(1);Cohen, N.(1);Traboulsi, C.(1);Rodriguez, T.(1);Steinberg, J.(1);Singer, J.(1);Patel, S.(1);Cohen, R.(1);Dalal, S.(1);Micic, D.(1);Pekow, J.(1);Sakuraba, A.(1);Rubin, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P456 Longer-term outcomes in acute severe colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. CAMPBELL, R. Haddock, K. Parman, J. MacDonald, J.P. Seenan

Created: Thursday, 30 January 2020, 10:12 AM
P456: Comparative analysis of oral versus intravenous iron in patients with inflammatory bowel disease and iron deficiency/anaemia – impact on hospitalisation in Germany
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Borchert K.1, Hardt T.2, Haas J.S.1, Ong S.H.3, Lechat E.1, Nip K.2, Foerster D.3, Braun S.1, Stein J.*4,5

Created: Wednesday, 20 February 2019, 10:36 AM
P456: Drug survival of thiopurine–allopurinol combination therapy in a real-life population-based cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.E. Kreijne1*, R.C. de Veer1, N.K. de Boer2, G. Bouma2, G. Dijkstra3, R.L. West4, A.A. van Bodegraven5, D.J. de Jong6, C.J. van der Woude1, A.C. de Vries1

Created: Thursday, 21 February 2019, 9:14 AM
P456: Efficacy and safety of TNF antagonist for the treatment of internal fistulising Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Huguet1, A.-L. Mallet1, V. Desfourneaux1, L. Siproudhis1, J.-F. Bretagne2, G. Bouguen*2

Created: Friday, 22 February 2019, 9:49 AM
P456: Ig glycosylation in ulcerative colitis: it's time for new biomarkers
Year: 2021
Source: ECCO'21 Virtual
Authors: Capecchi, R.(1);Migliorini, P.(1);Zanzi, F.(1);Maltinti, S.(1);Puxeddu, I.(1);De Bortoli, N.(1);Bellini, M.(1);Costa, F.(2);Marchi, S.(1);Bertani, L.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P456: Magnetic resonance enterography findings at week 46 after biological treatment predict long-term clinical outcomes in Crohn's disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fernandez Clotet, A.(1)*;Ordás, I.(2);Masamunt, M.C.(3);Caballol, B.(3);Rodriguez, S.(4);Panés, J.(3);Ricart, E.(5);Rimola, J.(4);
Created: Friday, 14 July 2023, 11:05 AM
P456: Quality of life is associated with wearable-based physical activity in patients with inflammatory bowel disease: a prospective, observational study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Wiestler*1, F. Kockelmann1, M. Kück2, A. Kerling2, U. Tegtbur2, M. P. Manns1, M. Attaran-Bandarabadi1, O. Bachmann1

Created: Friday, 22 February 2019, 9:41 AM
P456: Risk of malignant tumors in patients with autoimmune diseases on ustekinumab therapy: a systematic review and meta-analysis
Year: 2022
Source: ECCO'22
Authors: Huang, K.(1,2);Zhang, Y.(1,2);Yao, L.(1,2);Zhang, Z.(1,2);Liu, R.(1,2);Cao, Q.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P457 IBD couples and their offspring: a European survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Oliveira1, M.P. Costa-Santos1, C. Frias Gomes1, J. Sabino2, A. Sampaio3, L. Avedano4, S. Leone4, J.F. Colombel5, J. Torres1

Created: Thursday, 30 January 2020, 10:12 AM
P457: Biological interventions for induction and maintenance of mucosal healing in ulcerative colitis: A Cochrane systematic review
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Ricciuto1*, A. Al-Darmaki2, M.J. Stewart2, N.S. Ding3, H.H. Shim2, M. Storr4,5, R. Panaccione2, C. Seow2

Created: Thursday, 21 February 2019, 9:14 AM
P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Diederen*1, L. de Ridder2, P. van Rheenen3, V. Wolters4, L. Mearin5, G. Damen6, T. de Meij7, H. van Wering8, L. Tseng1, M. Oomen9, J. de Jong9, M. Benninga1, A. Kindermann1

Created: Friday, 22 February 2019, 9:49 AM
P457: Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Bastida*1, V. Bosó2, M. Aguas1, S. Bejar1, A. Garrido1, M. Iborra1, J. del Hoyo1, L. Tortosa1, D. Muñoz1, R. Marqués2, J. L. Poveda2, P. Nos1

Created: Friday, 22 February 2019, 9:41 AM
P457: Long-term cumulative safety of ustekinumab in bionaive patients with Crohn’s Disease and Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Danese, S.(1);Hanauer, S.B.(2);Jairath, V.(3,4);Mihaly, E.(5);Vicente Lidón, R.(6);Ott, E.(7);Gasink, C.(7);Miao, Y.(8);Ma, T.(8);Marano, C.(8);Sands, B.E.(9);
Created: Friday, 11 February 2022, 3:52 PM